Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about Roche to fully acquire Ignyta
Roche and Ignyta, Inc have entered into a definitive merger agreement for Roche to fully acquire Ignyta at a price of US$ 27.00 per share in an all-cash transaction. This corresponds to a total transaction value of US$ 1.7 billion on a fully diluted basis. This price represents a premium of 74% to Ignyta’s closing price on 21 December 2017 and a premium of 71% and 89% to Ignyta’s 30-day and 90-day volume weighted average share price on 21 December 2017, respectively. The merger agreement has been unanimously approved by the boards of Ignyta and Roche.

[adsense:336x280:8701650588]
- Read more about Allergan Acknowledges Appeals Court Decision for COMBIGAN®
Allergan plc a leading global pharmaceutical company, announced that the United States Court of Appeals for the Federal Circuit affirmed the United States District Court for the Eastern District of Texas' earlier decision that that each of three Allergan patents (U.S. Patent Nos. 7,030,149, 7,320,976 and 8,748,425) that are listed in the Orange Book for COMBIGAN® is valid. The Federal Circuit also affirmed the district court's finding that Sandoz' proposed generic version of COMBIGAN® does not infringe the '149 and '976 patents, and reversed the district court's decision that Sandoz' proposed generic product infringes the '425 patent.
- Read more about No impact on prices of Essential Drugs post introduction of GST in India
It is noticed that that there will be almost no impact on the prices of non-scheduled formulations which account for nearly 80% of the total pharmaceuticals sector, analysed by government.
- Read more about AMAG Pharmaceuticals received US patent for reducing risk of preterm birth
AMAG Pharmaceuticals, Inc announced the issuance of U.S. Patent Number 9,844,558 entitled “Methods of Reducing Risk of Preterm Birth.” This newly issued patent is directed to subcutaneous administration and dosing of Makena® (hydroxyprogesterone caproate injection) and is expected to expire on May 2, 2036. Makena is a treatment to reduce the risk of preterm birth in women who are pregnant with one baby and who spontaneously delivered one preterm baby in the past.
- Read more about Suven Life Sciences secures Product Patents in Canada and India
Suven Life Sciences Ltd (Suven) granted of one product patent from Canada (2932428) and one product patent from India (289123) corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2034 and 2028 respectively.
- Read more about Lincoln Pharma received Patent for Antimalarial Drug
Lincoln Pharmaceuticals Ltd. has been awarded a Patent for “An Arteether Injection For Treatment of Malaria”, Patent No.258915 by Government of India for Antimalarial Drug. In the present time, this formulation, “Arteether !njection”are available in market in 3ml and 2ml ampoules form. At the time of injecting “Arteether Injection” to the patient by doctors , it is very painful for a long time. Patient will have to take this injection at least for a period of three days to control the malaria.
- Read more about European Union nods Chugai's Lung Cancer medicine
F. Hoffmann-La Roche Ltd. obtained approval from the European Commission, for Alecensa® as monotherapy indicated for “the first-line treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC)”. In addition, the EU marketing authorisation for Alecensa has been switched from conditional approval (given in February 2017) to a full approval for the treatment of people with ALK-positive, metastatic NSCLC who have progressed on or are intolerant to crizotinib (second-line).
- Read more about Mentice acquires Endovascular Business from Medical Simulation Corporation
Mentice boosts its US development presence and adds a clinical training service line with the acquisition of Medical Simulation Corporation's (MSC) Medical Products division. Mentice is the global leader of simulation-based performance solutions for endovascular therapies.
- Read more about National Pharmacy Week Celebrations at RIPER
The Indian Pharmaceutical Association (IPA) Anantapuramu Local Branch, Head Quarters at Raghavendra Institute of Pharmaceutical Education and Research (RIPER), Anantapuramu celebrated the National Pharmacy Week (NPW) 2017, in association with University College of Pharmaceutical Sciences - Sri Krishnadevaraya University and Oil Technological and Pharmaceutical Research Institute - [OTPRI], Anantapuramu, Andhra Pradesh.
- Read more about Dr. Reddy’s settlement with the US Government regarding company’s compliance with the Consumer Product Safety Act
The US subsidiary of Dr. Reddy’s Laboratories Ltd. announced that it has reached a settlement with the US Government, in a case that is more than six years old, involving packaging for five blister-packed prescription products. In a joint filing by the parties, Dr. Reddy’s and the US Department of Justice agreed to the settlement of the action without any adjudication of any issue of fact or law.